Previous Article | Next Article ![]()
Infect Immun, July 1998, p. 3429-3432, Vol. 66, No. 7
Division of Geographic Medicine and
Infectious Diseases, New England Medical Center, Tufts University
School of Medicine, Boston, Massachusetts
02111,1 and
Division of Infectious
Diseases, Tufts University School of Veterinary Medicine, North
Grafton, Massachusetts 015362
Received 23 December 1997/Returned for modification 20 February
1998/Accepted 8 April 1998
An enzyme-linked immunosorbent assay-based attachment model using
the human intestinal cell line Caco-2A was developed to study
attachment of Cryptosporidium parvum sporozoites in vitro and to assess potential inhibitors of sporozoite binding. In this system, attachment was related to sporozoite dose, incubation time, and
host cell differentiation status. Polyclonal antibodies to C. parvum as well as glycoprotein inhibitors of a sporozoite lectin
reduced attachment. This model will be a valuable tool in elucidating
specific molecules and mechanisms involved in sporozoite-host cell
attachment.
The protozoan parasite
Cryptosporidium parvum is a causative agent of human
gastrointestinal disease worldwide (19). The illness is
self-limiting in immunocompetent individuals, but in immunocompromised
hosts it may result in severe diarrhea and wasting, for which no
effective therapy is currently available. Knowledge of the pathogenesis
of cryptosporidiosis is necessary in order to design preventative and
interventional strategies against this disease. Initial attachment of
the parasite to host cells is a prerequisite for the pathophysiological
events in infection. The molecular mechanisms and specific proteins
involved in adhesion of C. parvum sporozoites to host
epithelium have not yet been elucidated. Earlier studies
demonstrated the presence of a
galactose-N-acetylgalactosamine (Gal-GalNAc)-specific C. parvum sporozoite
surface lectin which may mediate attachment of sporozoites to host
cells (9, 23). To investigate the role of this lectin and
other putative adhesins in adherence of the parasite to intestinal
cells, it was important to establish a relevant and reliable in vitro
attachment model. Numerous assays with a variety of cell lines have
been reported for use as in vitro models to study the development of
C. parvum in host cells (2, 4, 7, 10, 11, 14, 18,
22, 27, 28). These include enzyme-linked immunosorbent assay
(ELISA)-based methods of measuring C. parvum infection
of human ileocecal adenocarcinoma cells (28) and human
intrahepatic biliary epithelial cells (27). The Caco-2
cell line has been widely used to investigate various biological
interactions of C. parvum with host cells. Buraud et al. (2) showed complete development (asexual and sexual) of C. parvum in Caco-2 cells. Subsequent reports
confirmed that this cell line supports C. parvum
infection to an extent comparable to that in other cell lines (14,
25, 27). Caco-2 cells have been used (i) to evaluate the
effects of anticryptosporidial drugs and antibodies on infection in
vitro (5, 11), (ii) to study C. parvum-induced intestinal epithelial cell secretory and transport defects (6, 7), and (iii) to investigate parasite-induced chemokine secretion by intestinal epithelial cells
(12). These studies indicate that Caco-2 cells are
well suited to investigations of the mechanisms involved in
C. parvum-intestinal cell interactions. In this
study we characterized attachment of sporozoites to these cells in
vitro using an ELISA-based model.
Parasites and cell culture.
C. parvum oocysts (GCH1
isolate) originally isolated from an AIDS patient were cultivated by
serial passages through neonatal calves (24). Oocysts were
purified and excysted and sporozoites were isolated as
described earlier (1). Caco-2 cells originally obtained from Hans Buller, Academic Medical Center, Amsterdam, The
Netherlands (26) were maintained and designated
Caco-2A by the GRASP Center Cell Culture Core at New England
Medical Center and provided to us as needed. Caco-2A cells
have been previously shown to support intracellular growth and
development of C. parvum (6, 27). Cells were
grown to confluence in Dulbecco's minimum essential medium (Gibco BRL,
Gaithersburg, Md.) supplemented with 10% (vol/vol) fetal calf serum,
25 mM HEPES, penicillin (100 U/ml), and streptomycin (100 µg/ml) for
72 h at 37°C in 5% CO2, in 96-well tissue
culture plates (Costar, Cambridge, Mass.) for the ELISA-based method and in collagen-coated 16-well Lab-Tek chamber slides
(Nunc, InterMed Corp., Naperville, Ill.) for the
immunofluorescence (IF)-based method.
Attachment assays.
In order to develop an ELISA-based assay
specific for attachment, Caco-2A monolayers were fixed to
prevent sporozoites from invading host cells. Fixation of host
cells does not appear to significantly affect sporozoite
attachment to erythrocytes or MDCK cells (8, 23). Fixed
target cells have been employed to investigate attachment of other
protozoan parasites, including Entamoeba histolytica
(3), Trypanosoma cruzi
(20), and Giardia lamblia (16). For
the ELISA-based method, cells were fixed with 1% (vol/vol)
glutaraldehyde in Hanks balanced salt solution containing 10 mM
HEPES (HBSS-HEPES), pH 7.2, for 10 min at room temperature (RT). For the IF-based method, cells were fixed with 4%
paraformaldehyde in phosphate-buffered saline for 30 min at RT
(8). Purified sporozoites in 50 µl of Dulbecco's minimum
essential medium, 25 mM HEPES, penicillin (100 U/ml), streptomycin (100 µg/ml), and 0.1% (wt/vol) bovine serum albumin (adhesion medium)
were incubated with fixed monolayers for 1 h at 37°C in 5%
CO2. Wells were washed twice with HBSS-HEPES, and adherent
sporozoites were fixed with methanol for 10 min at RT. After three
washes with Tris-buffered saline (TBS; 20 mM Tris-0.5 M NaCl [pH
7.5]), attached sporozoites were quantified by ELISA- and
IF-based methods. For the ELISA, nonspecific binding was blocked
with 1% (vol/vol) normal goat serum (NGS; Sigma Chemical Co., St.
Louis, Mo.) in TBS for 1 h at RT, followed by incubation with a
rabbit polyclonal anti-C. parvum antibody (which
recognizes sporozoites, but not oocysts) diluted 1:4,000 in 1% NGS-TBS
at 4°C overnight (8). After three washes with TBS, wells
were incubated for 1 h at RT with goat anti-rabbit immunoglobulin
G (IgG)-biotin conjugate (Vector Laboratories, Burlingame, Calif.) at
2 µg/ml in 1% NGS-TBS, washed three times with TBS, and incubated
with an avidin-biotin-alkaline phosphatase complex (ABC reagent; Vector
Laboratories) for 1 h at RT. Wells were washed five times with TBS
and incubated with p-nitrophenyl phosphate (1 mg/ml in 100 mM Tris-100 mM NaCl-5 mM MgCl2 [pH 9.5]) for 10 min at
RT. After termination of the reaction with 0.1 M EDTA, the absorption
at 405 nm (A405) was read against blanks in
which wells were processed identically except that sporozoites were not
added. Attachment was quantified by IF microscopy using a modification
of the method described earlier (8). After
nonspecific binding was blocked with 1% NGS-TBS for 1 h at RT,
slides were incubated with the rabbit antibody described above, diluted
1:6,000 in 1% NGS-TBS, overnight at 4°C. After three washes
with TBS, slides were incubated for 1 h at RT with goat
anti-rabbit IgG-fluorescein isothiocyanate conjugate (Sigma Chemical
Co.) diluted 1:80 in 1% NGS-TBS. Slides were washed three times,
mounted with buffered glycerol containing
p-phenylenediamine (1 mg/ml), and examined by
epifluorescence microscopy under oil immersion. The number of attached
sporozoites in 25 high-power fields (HPFs) per well was counted,
and the results were expressed as the number of sporozoites per HPF.
All assays were performed in triplicate, and the results were expressed
as the mean ± 1 standard error of the mean. Unpaired two-tailed
Student's t tests were used to evaluate differences. Differences were considered significant at the level at which P is <0.05.
Dose-response and time course studies.
Sporozoite attachment
to Caco-2A cells was shown to be dependent on the number of
parasites added (Fig. 1a). There was no significant signal obtained with heat-inactivated sporozoites (100°C,
10 min), confirming the specificity of the assay. Attachment was also dependent on incubation time, with maximal levels reached at
2 h (Fig. 1b). For subsequent assays an incubation time of 1 h was chosen to ensure sporozoite viability and to shorten the assay
time.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Attachment of Cryptosporidium parvum
Sporozoites to Human Intestinal Epithelial Cells


![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (18K):
[in a new window]
FIG. 1.
Dose-response and time course studies of attachment of
sporozoites to Caco-2A monolayers. (a) Live or heat-killed
sporozoites (1 × 105 to 20 × 105)
were incubated with fixed Caco-2A cells for 1 h, and
attachment was quantified by ELISA. (b) Sporozoites (105
per well) were incubated with fixed Caco-2A cells for the specified
periods, and attachment was quantified by ELISA. The number of attached
parasites is expressed as A405. Values are the
means ± standard errors of the means for triplicate samples.
Comparison of IF-based and ELISA-based methods. In a previous study, we used an immunofluorescent-antibody assay (IFA) to quantify sporozoite attachment to MDCK cells (8). Although the IFA is useful for direct visualization of attachment, it is time-consuming and subject to interobserver variation. In order to compare the ELISA-based and IF-based methods of quantifying attachment, the assays were performed in parallel with a wide range of sporozoite doses. For a given dose, the numbers of sporozoites per HPF obtained by IFA were correlated to the corresponding A405 values obtained by the ELISA, and the correlations were evaluated by linear regression analysis. A significant correlation was found between the numbers of attached sporozoites per HPF and the A405 values (r = 0.956; P < 0.0001). This indicated that while the ELISA was an indirect measure of sporozoite adhesion it nonetheless provided reliable and accurate results. Furthermore, there was less variation in replicate determinations in the ELISA than in the results obtained by IF microscopy.
Effect of differentiation of Caco-2A cells on sporozoite attachment. Upon growth in culture, Caco-2A cells differentiate to epithelium resembling that of the small intestine (21), exhibiting changes in cell surface glycoconjugates (29) and increased activities of specific enzymes such as alkaline phosphatase (15). To investigate whether differentiation of Caco-2A cells influences sporozoite attachment, monolayers were grown to confluence and examined at confluence and at 7 and 14 days postconfluence. At each time point the number of cells per well was determined in triplicate after trypsin-EDTA treatment to detach cells. The sporozoite attachment at each time point was assayed by ELISA and expressed as the A405 per 107 cells. As a marker of differentiation, the alkaline phosphatase activity of cells grown in parallel plates was determined in triplicate by incubation with 50 µl of p-nitrophenyl phosphate (1 mg/ml) for up to 10 min at RT. Absorbance at 405 nm was measured, and the enzyme activity was expressed as A405 per minute per cell. Increased differentiation over time was confirmed by an increase in alkaline phosphatase levels (Fig. 2). However, increased differentiation of Caco-2A cells resulted in a decrease in sporozoite attachment (Fig. 2). This suggests that maturation of Caco-2A cells leads to a reduction in the number of host cell receptors recognized by sporozoite adhesion molecules. These results are similar to those obtained with an in vitro model of E. histolytica interaction with Caco-2 cells, in which trophozoite adhesion to differentiated cells was found to be less extensive than that to undifferentiated cells (13). Interestingly, E. histolytica trophozoites also express a surface Gal-GalNAc-specific lectin which mediates attachment to host cells (reviewed in reference 17). Diminished attachment to differentiated Caco-2 cells was postulated to be related to a known decrease in the number of polylactosamine units (which may serve as carbohydrate receptors for the Gal-GalNAc-specific adhesion lectin) in differentiated cells (13, 29). This explanation may also hold true for diminished lectin-mediated adhesion of C. parvum sporozoites to differentiated Caco-2A cells.
|
Inhibition studies. (i) Polyclonal anti-C. parvum antibodies. In a previous study we showed that sporozoite attachment to MDCK cells was inhibited by rabbit and mouse polyclonal antibodies to C. parvum (8). In order to determine the effects of polyclonal antibodies on attachment to intestinal cells, we used hyperimmune bovine colostrum (HBC), which has been previously shown to inhibit C. parvum growth in vitro and in vivo and has also been used with some success for passive immunotherapy of C. parvum-infected patients (reviewed in reference 19). HBC Ig as well as bovine colostral Ig from a nonimmunized cow (as a control) was obtained as a gift from Joe Crabb, Immucell Corporation, Portland, Maine, and used at final concentrations of 10 and 100 µg/ml (4). As shown in Fig. 3a, antibodies to C. parvum present in HBC Ig inhibited attachment by 30% (P < 0.001) at a concentration of 100 µg/ml compared to the control. These findings indicate that antibodies which specifically block sporozoite attachment are present in HBC Ig and would likely contribute to reducing parasite infectivity. Interestingly, Doyle et al. showed that the same preparation of HBC Ig inhibited invasion and intracellular development of the parasite in MDCK cells by 45% at a concentration of 100 µg/ml (4).
|
(ii) Lectin-specific glycoproteins. We have previously described the presence of a Gal-GalNAc-specific lectin in C. parvum sporozoites (9, 23). Consistent with previous studies on lectin-receptor interactions (17), the sporozoite lectin exhibited a preference for complex carbohydrates. Lectin activity was more effectively inhibited by Gal-GalNAc-containing glycoproteins than by Gal or GalNAc. These glycoproteins were also shown to inhibit adhesion of C. parvum sporozoites to MDCK cells (9), suggesting that the lectin may mediate binding of the parasite to host cells. In order to determine whether these inhibitors block parasite attachment to Caco-2A cells, the attachment assay was performed in the presence of glycoproteins (Sigma Chemical Co.). Hog gastric mucin and bovine submaxillary mucin, which were the glycoproteins most inhibitory for lectin activity, also inhibited attachment to intestinal cells by 97% (P < 0.0001) and 75% (P < 0.0001), respectively (Fig. 3b). Orosomucoid and ovalbumin, which were noninhibitory for hemagglutinating activity, did not inhibit attachment. These findings suggest that the lectin may mediate sporozoite attachment to intestinal epithelial cells and warrant further investigation of its role in the host-parasite interaction.
The C. parvum-Caco-2A attachment assay will be a valuable model system for further investigation of the role of the sporozoite lectin and other potential adhesins in mediating adhesion to intestinal cells. From these studies, we hope to gain valuable insights into the molecular basis of a crucial step in C. parvum pathogenesis. The attachment assay also serves as a fast, reproducible, and quantitative means of screening potential inhibitors of sporozoite adhesion. Compounds which block parasite attachment to host cells may prove useful for developing new interventional therapies against cryptosporidiosis.| |
ACKNOWLEDGMENTS |
|---|
This work was supported by PHS grants AI33384 and AI40344 from NIAID and by the Cell Culture Core of the GRASP Digestive Disease Center, under grant P30 DK34928 from NIDDK. R.V. was supported by a fellowship from the Programme Lavoisier (Ministère des Affaires Etrangères, France).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: New England Medical Center, Division of Geographic Medicine and Infectious Diseases, 750 Washington St., NEMC Box 041, Boston, MA 02111. Phone: (617) 636-7032. Fax: (617) 636-3216. E-mail: honorine.ward{at}es.nemc.org.
Present address: Department of Medical Genetics and Microbiology,
University of Toronto, Ontario, Canada M5S 3E2.
Present address: Reanimation Medicale, Maladies Infectieuses et
Tropicales, Centre Hospitalier Universitaire Cote-de-Nacre, Caen 14033, France.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arrowood, M. J., and C. R. Sterling. 1987. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J. Parasitol. 73:314-319[Medline]. |
| 2. |
Buraud, M.,
E. Forget,
L. Favennec,
J. Bizet,
J.-G. Gobert, and A.-M. Deluol.
1991.
Sexual stage development of cryptosporidia in the Caco-2 cell line.
Infect. Immun.
59:4610-4613 |
| 3. |
Carrero, J. C.,
M. Y. Díaz,
M. Viveros,
B. Espinoza,
E. Acosta, and L. Ortiz-Ortiz.
1994.
Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells.
Infect. Immun.
62:764-767 |
| 4. |
Doyle, P. S.,
J. Crabb, and C. Petersen.
1993.
Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.
Infect. Immun.
61:4079-4084 |
| 5. | Favennec, L., M. Egraz-Bernard, E. Comby, D. Lemeteil, J. J. Ballet, and P. Brasseur. 1994. Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial agents. J. Eukaryot. Microbiol. 41:39S[Medline]. |
| 6. |
Griffiths, J. K.,
R. Moore,
S. Dooley,
G. T. Keusch, and S. Tzipori.
1994.
Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death.
Infect. Immun.
62:4506-4514 |
| 7. | Guarino, A., R. B. Canani, A. Casola, E. Pozio, R. Russo, E. Bruzzese, M. Fontana, and A. Rubino. 1995. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J. Infect. Dis. 171:976-983[Medline]. |
| 8. |
Hamer, D. H.,
H. Ward,
S. Tzipori,
M. E. A. Pereira,
J. P. Alroy, and G. T. Keusch.
1994.
Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro.
Infect. Immun.
62:2208-2213 |
| 9. | Joe, A., D. H. Hamer, M. A. Kelley, M. E. A. Pereira, G. T. Keusch, S. Tzipori, and H. D. Ward. 1994. Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J. Eukaryot. Microbiol. 41:44S[Medline]. |
| 10. | Kuhls, T. L., D. A. Mosier, and D. L. Crawford. 1991. Effects of carbohydrates and lectins on cryptosporidial sporozoite penetration of cultured cell monolayers. J. Protozool. 38:74S-76S[Medline]. |
| 11. | Langer, R. C., and M. W. Riggs. 1996. Neutralizing monoclonal antibody protects against Cryptosporidium parvum infection by inhibiting sporozoite attachment and invasion. J. Eukaryot. Microbiol. 43:76S-77S[Medline]. |
| 12. | Laurent, F., L. Eckmann, T. C. Savidge, G. Morgan, C. Theodos, M. Naciri, and M. F. Kagnoff. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65:5067-5073[Abstract]. |
| 13. |
Li, E.,
W. F. Stenson,
C. Kunz-Jenkins,
P. E. Swanson,
R. Duncan, and S. L. Stanley, Jr.
1994.
Entamoeba histolytica interactions with polarized human intestinal Caco-2 epithelial cells.
Infect. Immun.
62:5112-5119 |
| 14. | Maillot, C., L. Favennec, A. Francois, P. Ducrotte, and P. Brasseur. 1997. Sexual and asexual development of Cryptosporidium parvum in five oocyst- or sporozoite-infected human enterocytic cell lines. J. Eukaryot. Microbiol. 44:582-585[Medline]. |
| 15. | Matusumoto, H., R. H. Erickson, J. R. Gum, M. Yoshioka, E. Gum, and Y. S. Kim. 1990. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology 98:1199-1207[Medline]. |
| 16. |
McCabe, R. E.,
G. S. M. Yu,
C. Conteas,
P. R. Morrill, and B. McMorrow.
1991.
In vitro model of attachment of Giardia intestinalis trophozoites to IEC-6 cells, an intestinal cell line.
Antimicrob. Agents Chemother.
35:29-35 |
| 17. |
McCoy, J. J.,
B. J. Mann, and W. A. Petri, Jr.
1994.
Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around.
Infect. Immun.
62:3045-3050 |
| 18. |
McDonald, V.,
R. Stables,
D. C. Warhurst,
M. R. Barer,
D. A. Blewett,
H. D. Chapman,
G. M. Connolly,
P. L. Chiodini, and K. P. W. J. McAdam.
1990.
In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs.
Antimicrob. Agents Chemother.
34:1498-1500 |
| 19. | O'Donoghue, P. J. 1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:139-195[Medline]. |
| 20. | Ortega-Barria, E., and M. E. A. Pereira. 1991. A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell 67:411-421[Medline]. |
| 21. | Pinto, M., S. Robine-Leon, M.-D. Appay, M. Kedinger, E. Triadou, E. Dussauix, B. Lacroix, P. Simon-Assman, K. Haffen, J. Fogh, and A. Zweibaum. 1983. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47:323-330. |
| 22. |
Rasmussen, K. R.,
N. C. Larsen, and M. C. Healey.
1993.
Complete development of Cryptosporidium parvum in a human endometrial carcinoma cell line.
Infect. Immun.
61:1482-1485 |
| 23. | Thea, D. M., M. E. A. Pereira, D. Kotler, C. R. Sterling, and G. T. Keusch. 1992. Identification and partial purification of a lectin on the surface of the sporozoite Cryptosporidium parvum. J. Parasitol. 78:886-893[Medline]. |
| 24. | Tzipori, S., W. Rand, and C. Theodos. 1995. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum. J. Infect. Dis. 172:1160-1164[Medline]. |
| 25. | Upton, S. J., M. Tilley, and D. B. Brillhart. 1994. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 118:233-236[Medline]. |
| 26. | Van Beers, E. H., R. H. Al, E. H. Rings, A. W. Einerhand, J. Dekker, and H. A. Buller. 1995. Lactase and sucrase-isomaltase gene expression during Caco-2 cell differentiation. Biochem. J. 308:769-775. |
| 27. | Verdon, R., G. T. Keusch, S. Tzipori, S. M. Grubman, D. M. Jefferson, and H. D. Ward. 1997. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. J. Infect. Dis. 175:1268-1272[Medline]. |
| 28. | Woods, K. M., M. V. Nesterenko, and S. J. Upton. 1995. Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 128:89-94[Medline]. |
| 29. | Youakim, A., and A. Herscovics. 1987. Differentiation-associated decrease in the proportion of fucosylated polylactosaminoglycans of Caco-2 human colonic adenocarcinoma cells. Biochem. J. 247:299-306[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|